 - Chronic use of anti-platelet or anti-coagulation medication that cannot be temporarily discontinued for at least seven days prior to treatment with JX-594. Note: the following are allowed: low dose aspirin 100 mg, low dose coumadin as long as INR 1.4 and low-dose heparin to maintain port access 